155 related articles for article (PubMed ID: 32797669)
1. Quantity not sufficient rates and delays in sweat testing in US infants with cystic fibrosis.
McColley SA; Elbert A; Wu R; Ren CL; Sontag MK; LeGrys VA
Pediatr Pulmonol; 2020 Nov; 55(11):3053-3056. PubMed ID: 32797669
[TBL] [Abstract][Full Text] [Related]
2. Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.
Laguna TA; Lin N; Wang Q; Holme B; McNamara J; Regelmann WE
Pediatr Pulmonol; 2012 Aug; 47(8):736-42. PubMed ID: 22786625
[TBL] [Abstract][Full Text] [Related]
3. Predictors of insufficient sweat production during confirmatory testing for cystic fibrosis.
Kleyn M; Korzeniewski S; Grigorescu V; Young W; Homnick D; Goldstein-Filbrun A; Schuen J; Nasr S
Pediatr Pulmonol; 2011 Jan; 46(1):23-30. PubMed ID: 20812243
[TBL] [Abstract][Full Text] [Related]
4. Rate and predictors of insufficient sweat volume in very young infants after pilocarpine gel iontophoresis: prospective, population-based study.
Camargos P; Bedran RM; Alvim CG; Sader OG
Arch Dis Child; 2024 Mar; 109(4):304-307. PubMed ID: 38253430
[TBL] [Abstract][Full Text] [Related]
5. Newborn Screening for Cystic Fibrosis: Infant and Laboratory Factors Affecting Successful Sweat Test Completion.
Shenoy A; Spyropoulos D; Peeke K; Smith D; Cellucci M; Chidekel A
Int J Neonatal Screen; 2020 Dec; 7(1):. PubMed ID: 33375576
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for quantity not sufficient sweat collection in infants 3 months or younger.
Collins MN; Brawley CB; McCracken CE; Shankar PR; Schechter MS; Rogers BB
Am J Clin Pathol; 2014 Jul; 142(1):72-5. PubMed ID: 24926088
[TBL] [Abstract][Full Text] [Related]
7. Improving the Rate of Sufficient Sweat Collected in Infants Referred for Sweat Testing in Michigan.
Abdulhamid I; Kleyn M; Langbo C; Gregoire-Bottex M; Schuen J; Shanmugasundaram K; Nasr SZ
Glob Pediatr Health; 2014; 1():2333794X14553625. PubMed ID: 27335913
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a quality improvement program to improve sweat test performance in a pediatric hospital.
Aqil B; West A; Dowlin M; Tam E; Nordstrom C; Buffone G; Devaraj S
Arch Pathol Lab Med; 2014 Jul; 138(7):920-2. PubMed ID: 24568729
[TBL] [Abstract][Full Text] [Related]
9. Sweat-testing in preterm and full-term infants less than 6 weeks of age.
Eng W; LeGrys VA; Schechter MS; Laughon MM; Barker PM
Pediatr Pulmonol; 2005 Jul; 40(1):64-7. PubMed ID: 15880420
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of repeat sweat testing in cystic fibrosis newborn screen positive infants.
Bauer SE; Wesson M; Oles SK; Ren CL
Pediatr Pulmonol; 2021 Jun; 56(6):1521-1526. PubMed ID: 33512069
[TBL] [Abstract][Full Text] [Related]
11. Effects of immediate telephone follow-up with providers on sweat chloride test timing after cystic fibrosis newborn screening identifies a single mutation.
La Pean A; Farrell MH; Eskra KL; Farrell PM
J Pediatr; 2013 Mar; 162(3):522-9. PubMed ID: 23102590
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis newborn screening: outcome of infants with normal sweat tests.
Edmondson C; Grime C; Prasad A; Cowlard J; Nwokoro CEC; Ruiz G; Wallis C; Balfour-Lynn IM
Arch Dis Child; 2018 Aug; 103(8):753-756. PubMed ID: 29113966
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening.
Ren CL; Fink AK; Petren K; Borowitz DS; McColley SA; Sanders DB; Rosenfeld M; Marshall BC
Pediatrics; 2015 Jun; 135(6):e1386-92. PubMed ID: 25963008
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study.
Martiniano SL; Elbert AA; Farrell PM; Ren CL; Sontag MK; Wu R; McColley SA
Pediatr Pulmonol; 2021 Dec; 56(12):3758-3767. PubMed ID: 34469079
[TBL] [Abstract][Full Text] [Related]
15. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
16. Sweat testing infants detected by cystic fibrosis newborn screening.
Parad RB; Comeau AM; Dorkin HL; Dovey M; Gerstle R; Martin T; O'Sullivan BP
J Pediatr; 2005 Sep; 147(3 Suppl):S69-72. PubMed ID: 16202787
[TBL] [Abstract][Full Text] [Related]
17. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
[TBL] [Abstract][Full Text] [Related]
18. Inconclusive diagnosis of cystic fibrosis after newborn screening.
Ooi CY; Castellani C; Keenan K; Avolio J; Volpi S; Boland M; Kovesi T; Bjornson C; Chilvers MA; Morgan L; van Wylick R; Kent S; Price A; Solomon M; Tam K; Taylor L; Malitt KA; Ratjen F; Durie PR; Gonska T
Pediatrics; 2015 Jun; 135(6):e1377-85. PubMed ID: 25963003
[TBL] [Abstract][Full Text] [Related]
19. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
[TBL] [Abstract][Full Text] [Related]
20. Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life.
Leung DH; Heltshe SL; Borowitz D; Gelfond D; Kloster M; Heubi JE; Stalvey M; Ramsey BW;
JAMA Pediatr; 2017 Jun; 171(6):546-554. PubMed ID: 28437538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
